Reference
Therapeutic Goods Administration. Ceftriaxone and risk of hepatitis and encephalopathy Internet Document : 15 Dec 2021. Available from: URL: https://www.tga.gov.au/publication-issue/ceftriaxone-and-risk-hepatitis-and-encephalopathy
Rights and permissions
About this article
Cite this article
Ceftriaxone-related risk of hepatitis and encephalopathy. Reactions Weekly 1888, 3 (2022). https://doi.org/10.1007/s40278-022-08345-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-08345-9